Incidence and characteristics of viral community-acquired pneumonia in adults

Background: In adults, viral causes of community-acquired pneumonia (CAP) are poorly characterised. The aims of this study were to characterise the viral aetiology of CAP in adults by using an extensive array of viral diagnostic tests and to compare the characteristics of viral pneumonia with those of pneumococcal pneumonia. Methods: Adults admitted to Christchurch Hospital over a 1-year period with CAP were included in the study. Microbiological testing methods included blood and sputum cultures, urinary antigen testing for Streptococcus pneumoniae and Legionella pneumophila, antibody detection in paired sera and detection of respiratory viruses in nasopharyngeal swabs by immunofluorescence, culture and PCR. Results: Of 304 patients with CAP, a viral diagnosis was made in 88 (29%), with rhinoviruses and influenza A being the most common. Two or more pathogens were detected in 49 (16%) patients, 45 of whom had mixed viral and bacterial infections. There were no reliable clinical predictors of viral pneumonia, although several variables were independently associated with some aetiologies. The presence of myalgia was associated with pneumonia caused by any respiratory virus (OR 3.62, 95% CI 1.29 to 10.12) and influenza pneumonia (OR 190.72, 95% CI 3.68 to 9891.91). Mixed rhinovirus/pneumococcal infection was associated with severe disease. Conclusions: Virus-associated CAP is common in adults. Polymicrobial infections involving bacterial and viral pathogens are frequent and may be associated with severe pneumonia.

[1]  Alexander Rokitansky,et al.  Thorax , 2009, Pediatric Surgery Digest.

[2]  F. Hayden,et al.  Antivirals for influenza: historical perspectives and lessons learned. , 2006, Antiviral research.

[3]  S. Spector,et al.  Human Bocavirus: Prevalence and Clinical Spectrum at a Children's Hospital , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  J. McCullers.  Insights into the Interaction between Influenza Virus and Pneumococcus , 2006, Clinical Microbiology Reviews.

[5]  B. Berkhout,et al.  Human coronavirus NL63, a new respiratory virus , 2006, FEMS microbiology reviews.

[6]  F. Hayden,et al.  Picornavirus infections in children diagnosed by RT‐PCR during longitudinal surveillance with weekly sampling: Association with symptomatic illness and effect of season , 2006, Journal of medical virology.

[7]  A. Patick,et al.  Rhinovirus chemotherapy , 2006, Antiviral Research.

[8]  A. Torres,et al.  Mixed community-acquired pneumonia in hospitalised patients , 2006, European Respiratory Journal.

[9]  Robert F. Benson,et al.  Two Outbreaks of Severe Respiratory Disease in Nursing Homes Associated with Rhinovirus , 2006, Journal of the American Geriatrics Society.

[10]  S. Johnston,et al.  Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care , 2005, Thorax.

[11]  T. Pumarola,et al.  The Role of Viruses in the Aetiology of Community-Acquired Pneumonia in Adults , 2005, Antiviral therapy.

[12]  A. Torres,et al.  Guidelines for the management of adult lower respiratory tract infections , 2005, European Respiratory Journal.

[13]  F. Hayden,et al.  Relationship of Pleconaril Susceptibility and Clinical Outcomes in Treatment of Common Colds Caused by Rhinoviruses , 2005, Antimicrobial Agents and Chemotherapy.

[14]  Angus Nicoll,et al.  Avian influenza A (H5N1) infection in humans. , 2005, The New England journal of medicine.

[15]  E. Claas,et al.  Improved Diagnosis of the Etiology of Community-Acquired Pneumonia with Real-Time Polymerase Chain Reaction , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  G. Royo,et al.  Community-acquired pneumonia of mixed etiology: prevalence, clinical characteristics, and outcome , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[17]  J. Farrar,et al.  WRITING COMMITTEE OF THE WORLD HEALTH ORGANIZATION (WHO) CONSULTATION ON HUMAN INFLUENZA A/H5. AVIAN INFLUENZA A (H5N1) INFECTION IN HUMANS , 2005 .

[18]  B. RodrigoMoreno,et al.  [Etiology of community-acquired pneumonia in immunocompetent adults]. , 2005 .

[19]  J. M. Martínez Vázquez,et al.  Etiology of community-acquired pneumonia , 2005, European Journal of Clinical Microbiology.

[20]  D. Murdoch,et al.  Molecular genetic methods in the diagnosis of lower respiratory tract infections , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[21]  J. Crowe.  Human Metapneumovirus as a Major Cause of Human Respiratory Tract Disease , 2004, The Pediatric infectious disease journal.

[22]  D. Murdoch,et al.  Viral Etiology of Acute Respiratory Tract Infections in Children Presenting to Hospital: Role of Polymerase Chain Reaction and Demonstration of Multiple Infections , 2004, The Pediatric infectious disease journal.

[23]  N. Papadopoulos,et al.  Etiology of Community-Acquired Pneumonia in Hospitalized School-Age Children: Evidence for High Prevalence of Viral Infections , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  D. Murdoch,et al.  Human metapneumovirus in children with bronchiolitis or pneumonia in New Zealand , 2004, Journal of paediatrics and child health.

[25]  Shabir A Madhi,et al.  A role for Streptococcus pneumoniae in virus-associated pneumonia , 2004, Nature Medicine.

[26]  A. Torres,et al.  Viral community-acquired pneumonia in nonimmunocompromised adults. , 2004, Chest.

[27]  F. Hayden.  Rhinovirus and the lower respiratory tract† , 2004, Reviews in medical virology.

[28]  A. Danchin,et al.  The Severe Acute Respiratory Syndrome , 2003 .

[29]  Henry A. Erlich,et al.  The polymerase chain reaction. , 1989, Trends in genetics : TIG.

[30]  S. Ishizuka,et al.  Effects of rhinovirus infection on the adherence of Streptococcus pneumoniae to cultured human airway epithelial cells. , 2003, The Journal of infectious diseases.

[31]  John G. Bartlett,et al.  Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  W. Lim,et al.  Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study , 2003, Thorax.

[33]  M. Rozenberg-Arska,et al.  Polymerase Chain Reaction Is More Sensitive than Viral Culture and Antigen Testing for the Detection of Respiratory Viruses in Adults with Hematological Cancer and Pneumonia , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  D. Murdoch,et al.  Community-acquired pneumonia in Christchurch and Waikato 1999-2000: microbiology and epidemiology. , 2001, The New Zealand medical journal.

[35]  D. Murdoch,et al.  Evaluation of a Rapid Immunochromatographic Test for Detection of Streptococcus pneumoniae Antigen in Urine Samples from Adults with Community-Acquired Pneumonia , 2001, Journal of Clinical Microbiology.

[36]  M. Fine,et al.  Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. , 2001, American journal of respiratory and critical care medicine.

[37]  N. Papadopoulos,et al.  Rhinoviruses infect the lower airways. , 2000, The Journal of infectious diseases.

[38]  O. Ruuskanen,et al.  Etiology of community‐acquired pneumonia in 254 hospitalized children , 2000, The Pediatric infectious disease journal.

[39]  Sheldon P Stone,et al.  Community-acquired pneumonia , 1998, The Lancet.

[40]  M. Fine,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[41]  V. Hammersley,et al.  Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community: prospective cohort study , 1996, BMJ.

[42]  S. Gravenstein,et al.  A Rhinovirus Outbreak among Residents of a Long-Term Care Facility , 1995, Annals of Internal Medicine.

[43]  L. Bakaletz,et al.  Viral potentiation of bacterial superinfection of the respiratory tract. , 1995, Trends in microbiology.

[44]  E. R. Mcfadden,et al.  Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. , 1990, The Journal of clinical investigation.

[45]  R. L. Taylor,et al.  Guidelines for management , 1972 .